D-Serine in the Treatment of Psychosis
D-Serine in the Treatment of Psychosis
复制标题
D-丝氨酸治疗精神病
DOI:
10.1007/978-3-319-56015-1_391-1
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Masakazu Umino
中科院分区:
文献类型:
--
作者:
Toru Nishikawa;Asami Umino;Masakazu Umino
This chapter is intended to provide fundamental information about D-serine and its application to adjunctive pharmacotherapy with currently used antipsychotics for schizophrenia. In the first sections, the chemical structures and features of the metabolism, pharmacology, and pharmacokinetics of D-serine are introduced. In particular, the interaction between D-serine and theN-methyl-D-aspartate-type glutamate receptor (NMDA receptor) consisting of GluN1/GluN2 subunits, which is the basis for the therapeutic action of D-serine on schizophrenia, is explained, and the effects of D-serine on the NMDA receptor including GluN1/GluN3 subunits and the GluD2-type glutamate receptor are also discussed. The consecutive sections describe the clinical indications of D-serine under investigation for the pharmacotherapy of schizophrenia and other neuropsychiatric disorders, and summarize the clinical trials of add-on D-serine in schizophrenia and schizoaffective disorder and their efficacy for presently available antipsychotic-resistant symptoms in these disorders. Furthermore, the overviews and conclusions of the meta-analyses of these trials are listed. The last sections mention the adverse events, tolerability, and safety during the clinical treatment with D-serine.
登录
查看更多内容
影响因子:
4.7
作者:
M. Matoba;U. Tomita;T. Nishikawa
通讯作者:
M. Matoba;U. Tomita;T. Nishikawa
影响因子:
--
作者:
Lane, HY;Chang, YC;Tsai, GE
通讯作者:
Tsai, GE
影响因子:
4.8
作者:
A. Umino;Sayuri Ishiwata;H. Iwama;T. Nishikawa
通讯作者:
T. Nishikawa
影响因子:
--
作者:
J. Kane;G. Honigfeld;J. Singer;H. Meltzer
通讯作者:
J. Kane;G. Honigfeld;J. Singer;H. Meltzer
影响因子:
4.5
作者:
Kantrowitz, Joshua T.;Epstein, Michael L.;Javitt, Daniel C.
通讯作者:
Javitt, Daniel C.